ALVR Allovir Inc

Price (delayed)

$18.75

Market cap

$1.22B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.17

Enterprise value

$1.06B

Highlights
ALVR's EPS has shrunk by 100% QoQ but it has soared by 73% YoY
The quick ratio is up by 44% year-on-year but it has declined by 25% since the previous quarter
The net income has dropped by 198% year-on-year and by 31% since the previous quarter
The equity has declined by 6% since the previous quarter

Key stats

What are the main financial stats of ALVR
Market
Shares outstanding
65.11M
Market cap
$1.22B
Enterprise value
$1.06B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
3.7
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$91.37M
EBITDA
-$91.24M
Free cash flow
-$69.5M
Per share
EPS
-$5.17
Free cash flow per share
-$1.12
Book value per share
$5.07
Revenue per share
$0
TBVPS
$5.65
Balance sheet
Total assets
$351.28M
Total liabilities
$20.91M
Debt
$10.2M
Equity
$330.37M
Working capital
$324.16M
Liquidity
Debt to equity
0.03
Current ratio
21.91
Quick ratio
21.74
Net debt/EBITDA
1.74
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-29.6%
Return on equity
-37.1%
Return on invested capital
-51.5%
Return on capital employed
-27.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALVR stock price

How has the Allovir stock price performed over time
Intraday
4.34%
1 week
6.35%
1 month
-10.8%
1 year
N/A
YTD
-51.22%
QTD
-5.02%

Financial performance

How have Allovir's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$92.33M
Net income
-$91.37M
Gross margin
N/A
Net margin
N/A
The net income has dropped by 198% year-on-year and by 31% since the previous quarter
The operating income has plunged by 173% YoY and by 29% from the previous quarter

Growth

What is Allovir's growth rate over time

Valuation

What is Allovir stock price valuation
P/E
N/A
P/B
3.7
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ALVR's EPS has shrunk by 100% QoQ but it has soared by 73% YoY
The equity has declined by 6% since the previous quarter

Efficiency

How efficient is Allovir business performance
The return on assets has declined by 24% year-on-year and by 7% since the previous quarter
ALVR's return on equity is up by 21% since the previous quarter
Allovir's return on invested capital has decreased by 14% YoY and by 11% QoQ

Dividends

What is ALVR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALVR.

Financial health

How did Allovir financials performed over time
The total assets has surged by 173% year-on-year but it has declined by 5% since the previous quarter
The quick ratio is up by 44% year-on-year but it has declined by 25% since the previous quarter
Allovir's debt is 97% less than its equity
ALVR's debt to equity has soared by 117% year-on-year and by 50% since the previous quarter
Allovir's debt has increased by 17% from the previous quarter but it has decreased by 7% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.